362
Views
11
CrossRef citations to date
0
Altmetric
Review

Pharmacotherapeutic strategies for standard treatment-resistant psoriasis

, , , & ORCID Icon
Pages 443-454 | Received 06 Aug 2018, Accepted 13 Dec 2018, Published online: 27 Dec 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Claire Ervin, Rebecca Crawford, Emily Evans, Steven R. Feldman, Joshua Zeichner, Michael A. Zielinski, Joseph C. Cappelleri, Marco DiBonaventura, Liza Takiya & Daniela E. Myers. (2022) Patient and caregiver preferences on treatment attributes for atopic dermatitis. Journal of Dermatological Treatment 33:4, pages 2225-2233.
Read now

Articles from other publishers (10)

Andrea Roso-Mares, Isabel Andújar, Tania Díaz Corpas & Bryan K. Sun. (2023) Non-coding RNAs as skin disease biomarkers, molecular signatures, and therapeutic targets. Human Genetics.
Crossref
Lisza Niarisessa, Anisa Nova Puspitaningrum, Arief Rahman Afief, Dyah Aryani Perwitasari, Wirawan Adikusuma, Rocky Cheung, Abdi Wira Septama & Lalu Muhammad Irham. (2023) Identification of Biological Risk Genes and Candidate Drugs for Psoriasis Vulgaris by Utilizing the Genomic Information. Borneo Journal of Pharmacy 6:2, pages 110-119.
Crossref
Xiaoman Yuan, Bin Tang, Yilan Chen, Lijuan Zhou, Jingwen Deng, Lin Han, Yonggong Zhai, Yandong Zhou, Donald L. Gill, Chuanjian Lu & Youjun Wang. (2023) Celastrol inhibits store operated calcium entry and suppresses psoriasis. Frontiers in Pharmacology 14.
Crossref
Adam Wroński, Iwona Jarocka-Karpowicz, Anna Stasiewicz & Elżbieta Skrzydlewska. (2023) Phytocannabinoids in the Pharmacotherapy of Psoriasis. Molecules 28:3, pages 1192.
Crossref
Xiao Wu, Qihui Yin, Jie Wang, Chaochao Dai, Jianli Wang, Xiaosun Guo & Fan Jiang. (2022) Novel RNA polymerase I inhibitor CX ‐5461 suppresses imiquimod‐induced experimental psoriasis . Experimental Dermatology 32:1, pages 91-99.
Crossref
Francisco Ciruela & Kenneth A. Jacobson. (2022) Optical Control of Adenosine A3 Receptor Signaling: Towards a Multimodal Phototherapy in Psoriasis?. Frontiers in Immunology 13.
Crossref
Yue Lu, Haiming Chen, Junhong Zhang, Bin Tang, Hongyu Zhang, Changju Ma, Xiaojuan Tang, Li Li, Jingjing Wu, Jianan Wei, Shaoping Li, Lei Yang, Ling Han & Chuanjian Lu. (2021) Fuzhenghefuzhiyang Formula (FZHFZY) Improves Epidermal Differentiation via Suppression of the Akt/mTORC1/S6K1 Signalling Pathway in Psoriatic Models. Frontiers in Pharmacology 12.
Crossref
Muhammad Ali Muslimani, Vittorio Bolcato, Annalisa Silvestri & Valeria Brazzelli. (2020) Psoriatic patients undergoing long‐term therapy with biologics: Impact of residual localization of psoriasis on quality of life in an Italian clinical setting. Dermatologic Therapy 33:6.
Crossref
Alexander S. Zhukov, Vladislav R. Khairutdinov & Aleksey V. Samtsov. (2020) Comparative study of anti-inflammatory activity of zinc pyrition on a psoriasis laboratory model. Vestnik dermatologii i venerologii 96:2, pages 64-70.
Crossref
A. S. Zhukov, V. R. Khairutdinov & A. V. Samtsov. (2020) Precision therapy for psoriasis patients. Vestnik dermatologii i venerologii 95:6, pages 14-21.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.